Wire Stories
-
652Osel Announces Positive Results from Phase 1b Trial of Live Biotherapeutic Product CBM588 in Combination with Checkpoint Inhibitor (CPI) Therapy in Metastatic Renal Cell Carcinoma
— CBM588 plus nivolumab/ipilimumab improved ORR and PFS compared to nivolumab/ipilimumab alone — — First randomized study to prospectively assess a live...
-
762
Alipay and Helbiz Renew Their Commitment to Restart Tourism ahead of the European Soccer Championship
Helbiz will be featured on the Alipay app to help tourists seamlessly locate and rent its micro-mobility vehicles MILAN–(BUSINESS WIRE)–Helbiz, a global...
-
671
Strategy Analytics: Trade War and Shortages Fuel China�s Semiconductor Self-Sufficiency
Targeted Investments and Incentives Show Progress in Higher Demand Mature Process Nodes BOSTON–(BUSINESS WIRE)–According to Strategy Analytics, sanctions and the semiconductor shortage...
-
602
Radware Schedules Conference Call for Its Second Quarter 2021 Earnings
TEL AVIV, Israel, June 07, 2021 (GLOBE NEWSWIRE) — Radware� (NASDAQ: RDWR), a leading provider of cyber security and application delivery solutions,...
-
620
Borqs Technologies Receives 1.7 Million sq.ft. Land Use Rights for the 5G Industrial Park Project in Huzhou, China
SANTA CLARA, Calif., June 07, 2021 (GLOBE NEWSWIRE) — Borqs Technologies, Inc. (Nasdaq: BRQS, �Borqs�, or the �Company�), a global provider of...
-
525
OIF Thought Leaders to Provide Updates on Co-Packaging, 400ZR, Electrical Data Rates and Transport SDN Projects at Global Conferences
Presenting developments on innovative projects at OFC 2021, Optinet China 2021 and China Fiber Connect Forum 2021 FREMONT, Calif.–(BUSINESS WIRE)–#400zr—OIF thought leaders...
-
615
Allyson Felix Defines Her Legacy Ahead of Tokyo 2020 with Pantene�s �What�s Your Legacy� Campaign
Pantene announces partnership with Six-Time Olympic Gold Medalist, Mother, and Activist, Allyson Felix, to celebrate the everyday moments that shape a legacy...
-
601
IASO Biotherapeutics Application for Clinical Trials of the Second Indication of its Fully Human CD19/CD22 Dual-targeted CAR-T Drug Accepted by NMPA
PLEASANTON, Calif. & NANJING, China–(BUSINESS WIRE)–#Biopharmaceutical—IASO Biotherapeutics, a clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for...
-
743
Rayence Launches 3D Inline AXI Detector, MIDAS 2121
HWASEONG, South Korea–(BUSINESS WIRE)–#3DInlineAXI—Rayence (KOSDAQ: 228850, www.rayence.com), a manufacturer of digital x-ray detectors, announced that it has launched a high-speed, real-time 3D...
-
681
Phase 3 Clinical Trial Subgroup Analysis Across Solid Organ Transplant (SOT) Types Supports Efficacy of Maribavir Over Conventional Therapies in Post-Transplant Recipients With Cytomegalovirus (CMV) Infection (Refractory, With or Without Resistance)
Building Upon Previous Data Showing More Than Twice as Many SOT Recipients Receiving Maribavir Achieved CMV Viremia Clearance Compared to Conventional Antiviral...
